Medicare's $50 obesity drug program is proving popular
Reported byNPR Health ↗·Sourced by Goodlede
The Bridge program, which began July 1, made obesity drugs available to eligible Medicare beneficiaries for $50 a month. CVS and Walgreens each filled around 100,000 prescriptions in the first two months, with roughly half of Walgreens' patients new to GLP-1 drugs.
Beneficiaries are ineligible if they have sleep apnea or Type 2 diabetes, because those conditions should already have coverage under Medicare Part D. The program runs through the end of 2027.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at NPR Health
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Health
Treatment involving patient's family cuts mental health hospital admissions, study finds
BBC Health · Verified
Equality
Lyft Removes Barrier For Riders With Developmental Disabilities
Disability Scoop · Verified
Health
FDA approves landmark pancreatic cancer drug that's shown to improve survival
NPR Health · Verified